Differences in C/EBPs in normal tissue and papillomas of the larynx

Cell Proliferation

Volumn 31, Issue 3-4, 1998, Pages 127-138

  Jin, L ^a   Yang, G Y ^b   Auborn, K ^a,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c LONG ISLAND JEWISH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL DIFFERENTIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LARYNX PAPILLOMATOSIS; SOUTHERN BLOTTING; SQUAMOUS EPITHELIUM;

PAPILLOMAVIRUS;

EID: 0031792895     PISSN: 09607722     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2184.1998.tb01191.x     Document Type: Article

References (26)

1. AN MR, HSIEH CC, REISNER PD, RABEK JP, SCOTT SG, KUNINGER DT, PAPACONSTANTINOU J. (1996) Evidence for posttranscriptional regulation of C/EBPalpha and C/EBPbeta isoform expression during the lipopolysaccharide-mediated acute-phase response. Mol. Cell. Biol. 16, 2295.
2. ABRAMSON AL, STEINBERG BM, WINKLER B. (1987) Laryngeal papillomatosis: clinical, histopathologic and molecular studies. Laryngoscope 97, 678.
3. AUBORN KJ, GALLI RL, DILORENZO TP, STEINBERG BM. (1989) Identification of DNA-protein interactions and enhancer activity at the 5′ end of the upstream regulatory region in human papillomavirus type 11. Virology 170, 123.
4. AUBORN KJ, STEINBERG BM. (1991) A key DNA-protein interaction determines the function of the 5′URR enhancer in human papillomavirus type 11. Virology 181, 132.
5. AUGHT B, LIAO WS, ROSEN JM. (1995) Developmentally and homonally regulated CCAAT/enhancer-binding protein isoforms influence beta-casein gene expression. Mol. Endocrinol. 9, 1223.
6. BOUDREAU F, BLAIS S, ASSELIN C. (1996) Regulation of CCAAT/enhancer binding protein isoforms by serum and glucocorticoids in the rat intestinal epithelial crypt cell line IEC-6. Exp. Cell. Res. 222, 1.
7. CAO Z, UMEK RM, MCKNIGHT SL. (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes. Dev. 5, 1538.
8. Descombes P, Schibler U. (1991) A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA. Cell 67, 569.
9. FERENCZY A, MITAO M, NAGAI N, SILVERSTEIN SJ, CRUM CP. (1985) Latent papillomavirus and recurring genital warts. N. Engl. J. Med. 313, 784.
10. GISSMANN L, WOLNIK L, IKENBERG H et al. (1993) Human papillomavirus types 6 and 11 dDNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc. Natl. Acad. Sci. USA 80, 560.
11. HENDRICKS-TAYLOR LR, DARLINGTON GJ. (1995) Inhibition of cell proliferation by C/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen. Nucleic Acid Res. 23, 4726.
12. ISSHIKI H, AKIRA S, SUGITA T et al. (1991) Reciprocal expression of NF-IL6 and C/EBP in hepatocytes: possible involvement of NF-IL6 in acute phase protein gene expression. New Biol. 3, 63.
13. KATZ S, KOWENZ-LEUTZ E, MULLER C et al. (1993) The NF-M transcription factor is related to C/EBP beta and plays a role in signal transduction, differentiation and leukemogenesis of avian myelomonocytic cells. Embo. J. 12, 1321.
14. LIN FT, LANE MD. (1992) Antisense CCAAT/enhancer-binding protein RNA suppresses coordinate gene expression and triglyceride accumulation during differentiation of 3T3-L1 preadipocytes. Genes Dev. 6, 533.
15. LIN FT, MACDOUGALD OA, DIEHL AM, LAND MD. (1993) A 30-kD alternative translation product of the CCAAT/enhancer binding protein alpha message: transcriptional activator lacking antimitotic activity. Proc. Natl. Acad. Sci. USA. 90, 9606.
16. MARAN A, AMELLA CA, DILORENZO TP et al. (1995) Human papillomavirus type 11 transcripts are presents at low abundance in latently infected respiratory tissues. Virology 212, 285.
17. OSSIPOW V, DESCOMBES P, SCHIBLER U. (1993) CCAATG/enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc. Natl. Acad. Sci. USA 90, 8219.
18. RAUGHT B, GINGRAS AC, JAMES A et al. (1996) Expression of a translationally regulated, dominant-negative CCAAT/enhancer-binding protein beta isoform and up-regulation of the eukaryotic translation initiation factor 2 alpha are corrected with neoplastic transformation of mammary epithelial cells. Cancer Res. 56, 4382.
19. SCOTT LM, CIVIN CI, RORTH P, FRIEDMAN AD. (1992) A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80, 1725.
20. STEINBERG BM, MEAD R, KALINOWSKI S, ABRAMSON AL. (1990) Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch. Otolaryngol. Head Neck Surg. 116, 1167.
21. STEINBERG BM, TOPP WC, SCHNEIDER PS, ABRAMSON AL. (1983) Laryngeal papillomavirus infection during clinical remission. N. Engl. J. Med. 308, 1261.
22. STOLER MH, WHITBECK A, WOLINSKY SM et al. (1990) Infectious cycle of human papillomavirus type 11 in human foreskin xenografts in nude mice. J. Virol. 64, 3310.
23. STOLER MH, WOLINSKY SM, WHITBECK A et al. (1989) Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 172, 331.
24. UMEK RM, FRIEDMAN AD, MCKNIGHT SL. (1991) CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251, 288.
25. WANG H, LIU K, YUAN F, BERDICHEVSKY L et al. (1996) C/EBP beta is a negative regulator of human papillomavirus type 11 in keratinocytes. J. Virol. 70, 4839.
26. WILLIAMS SC, CANTWELL CA, JOHNSON PF. (1991) A family of C/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro. Genes Dev. 5, 1553.